Literature DB >> 32471614

Revision Surgery for Failed Total Ankle Replacement.

Byron Hutchinson1, Mallory J Schweitzer2.   

Abstract

Revision surgery for failed total ankle replacement is a challenge to the revision surgeon. Deformity, presence of infection, segmental bone defects, patient comorbidities, and soft tissue compromise all are significant considerations when determining appropriate procedures. Revision total ankle replacement, explant and fusion with or without lengthening, use of a trabecular metal cage, placement of an antibiotic cement spacer, grafting, and amputation all are viable options to treat patients with failed ankle arthroplasty.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Circular fixation; Custom trabecular metal cages; Femoral head allograft; Segmental bone defect; Total ankle replacement

Year:  2020        PMID: 32471614     DOI: 10.1016/j.cpm.2020.03.004

Source DB:  PubMed          Journal:  Clin Podiatr Med Surg        ISSN: 0891-8422            Impact factor:   1.231


  4 in total

1.  A Novel Method for Preoperative Positioning of Total Ankle Replacement Using 3D Digital Model.

Authors:  Shi-Xun Wu; Shi-Zhang Liu; Ming Ling; Yan-Hui Che; Xin Tian; Xiang-Long Duan; Zhi Yi
Journal:  Orthop Surg       Date:  2022-06-03       Impact factor: 2.279

2.  Failure rates and patient-reported outcomes of revision of total ankle arthroplasty.

Authors:  Kathrin Pfahl; Anke Röser; Julia Eder; Oliver Gottschalk; Hubert Hörterer; Alexander Mehlhorn; Markus Walther
Journal:  Arch Orthop Trauma Surg       Date:  2022-10-21       Impact factor: 2.928

Review 3.  The Utility of Isotropic 3D Magnetic Resonance Imaging in Assessing Painful Total Ankle Replacements.

Authors:  Ji Lin; Carolyn M Sofka; Constantine A Demetracopoulos; Hollis G Potter
Journal:  Foot Ankle Orthop       Date:  2022-04-30

4.  Associated Corrective Procedures of Extra-Articular Asymptomatic Foot Malalignments in Total Ankle Replacement: Are They Really Mandatory?

Authors:  Silvio Caravelli; Marco Di Ponte; Alberto Grassi; Stefano Zaffagnini; Massimiliano Mosca
Journal:  J Clin Med       Date:  2022-08-04       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.